the news company writes.

‘China’s entry into this field is certainly important because one child dies every 20 seconds from vaccine-preventable diseases each year,’ the news company writes, adding that the country’s ‘vaccine makers, some of whom currently export in small amounts, are confident they’ll shortly become big players in the field’ .This article was reprinted from with permission from the Henry J . Kaiser Family members Foundation. Kaiser Health News, an independent news service editorially, is an application of the Kaiser Family Foundation, a nonpartisan health care policy research business unaffiliated with Kaiser Permanente..

read more

Astellas reports efficacy, basic safety data of isavuconazole invasive aspergillosis SECURE study at ECCMID Astellas reported today that the efficacy and security data of the isavuconazole invasive aspergillosis study were presented at the European Congress of Clinical Microbiology and Infectious Illnesses in Barcelona, Spain. Announced topline data showed that the randomized Previously, double-blind SECURE study met the primary objective of demonstrating non-inferiority of isavuconazole versus voriconazole for the principal treatment of invasive fungal disease due to Aspergillus species or certain various other filamentous fungi.